DBH -1021C>T and COMT Val108/158Met genotype are not associated with the P300 ERP in an auditory oddball task

Clinical Neurophysiology

Volumn 124, Issue 5, 2013, Pages 909-915

  Spronk, D B ^a,c   Veth, C P M ^a,b   Arns, M ^b,d   Schofield, P R ^e,f   Dobson Stone, C ^e,f   Ramaekers, J G ^g   Franke, B ^a,c   de Bruijn, E R A ^h   Verkes, R J ^a,c  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RESEARCH INSTITUTE BRAINCLINICS   (Netherlands)

^c RADBOUD UNIVERSITY   (Netherlands)

^d UTRECHT UNIVERSITY   (Netherlands)

^e NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^f UNIVERSITY OF NEW SOUTH WALES   (Australia)

^g MAASTRICHT UNIVERSITY   (Netherlands)

^h LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Brain Research and Integrative Neuroscience Network (BRAINnet); COMT; DBH; Dopamine; Endophenotype; ERP; Genomics; P3; P300; Polymorphisms

Indexed keywords

CATECHOL METHYLTRANSFERASE; DOPAMINE BETA MONOOXYGENASE; GENOMIC DNA; METHIONINE; VALINE;

AMPLITUDE MODULATION; ARTICLE; AUDITORY STIMULATION; DEMOGRAPHY; ELECTRODE; ELECTROENCEPHALOGRAPHY; EVENT RELATED POTENTIAL; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN EXPERIMENT; LATENT PERIOD; MALE; NORMAL HUMAN; PRIORITY JOURNAL; QUESTIONNAIRE; SELF REPORT; SINGLE NUCLEOTIDE POLYMORPHISM; STIMULUS RESPONSE; TASK PERFORMANCE;

ADOLESCENT; ADULT; AGED; CATECHOL O-METHYLTRANSFERASE; DOPAMINE BETA-HYDROXYLASE; EVENT-RELATED POTENTIALS, P300; EVOKED POTENTIALS, AUDITORY; FEMALE; GENOTYPE; HUMANS; MALE; METHIONINE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; POLYMORPHISM, SINGLE NUCLEOTIDE; VALINE; YOUNG ADULT;

EID: 84876154402     PISSN: 13882457     EISSN: 18728952     Source Type: Journal    
DOI: 10.1016/j.clinph.2012.11.008     Document Type: Article

References (63)

1. Akil M., Kolachana B.S., Rothmond D.A., Hyde T.M., Weinberger D.R., Kleinman J.E. Catechol-O-methyltransferase genotype and dopamine regulation in the human brain. J Neurosci 2003, 23:2008-2013.
2. Albrecht M.A., Martin-Iverson M.T., Price G., Lee J., Iyyalol R. Dexamphetamine-induced reduction of P3a and P3b in healthy participants. J Psychopharmacol 2011, 25:1623-1631.
3. Barnett J.H., Jones P.B., Robbins T.W., Muller U. Effects of the catechol-O-methyltransferase Val158Met polymorphism on executive function: a meta-analysis of the Wisconsin Card Sort Test in schizophrenia and healthy controls. Mol Psychiatry 2007, 12:502-509.
4. Barnett J.H., Scoriels L., Munafò M.R. Meta-analysis of the cognitive effects of the catechol-O-methyltransferase gene Val158/108Met polymorphism. Biol Psychiatry 2008, 64:137-144.
5. Berman S.M., Noble E.P., Antolin T., Sheen C., Conner B.T., Ritchie T. P300 development during adolescence. effects of DRD2 genotype. Clin Neurophysiol 2006, 117:649-659.
6. Beste C., Domschke K., Kolev V., Yordanova J., Baffa A., Falkenstein M., et al. Functional 5-HT1a receptor polymorphism selectively modulates error-specific subprocesses of performance monitoring. Hum Brain Mapp 2010, 31:621-630.
7. Bilder R.M., Volavka J., Czobor P., Malhotra A.K., Kennedy J.L., Ni X.Q., et al. Neurocognitive correlates of the COMT Val (158)Met polymorphism in chronic schizophrenia. Biol Psychiatry 2002, 52:701-707.
8. Birkas E., Horvath J., Lakatos K., Nemoda Z., Sasvari-Szekely M., Winkler I., et al. Association between dopamine D4 receptor (DRD4) gene polymorphisms and novelty-elicited auditory event-related potentials in preschool children. Brain Res 2006, 1103:150-158.
9. Bramon E., Dempster E., Frangou S., McDonald C., Schoenberg P., MacCabe J.H., et al. Is there an association between the COMT gene and P300 endophenotypes?. Eur Psychiatry 2006, 21:70-73.
10. Bramon E., McDonald C., Croft R.J., Landau S., Filbey F., Gruzelier J.H., et al. Is the P300 wave an endophenotype for schizophrenia? A meta-analysis and a family study. Neuroimage 2005, 27:960-968.
11. Bruder G.E., Keilp J.G., Xu H., Shikhman M., Schori E., Gorman J.M., et al. Catechol-O-methyltransferase (COMT) genotypes and working memory: associations with differing cognitive operations. Biol Psychiatry 2005, 58:901-907.
12. Chen C., Chen C., Moyzis R., He Q., Li H., Li J., et al. Genetic variations in the dopaminergic system and alcohol use: a system-level analysis. Addict Biol 2012, 17:479-489.
13. de Wilde O.M., Bour L.J., Dingemans P.M., Koelman J.H., Boeree T., Linszen D.H. P300 deficits are present in young first-episode patients with schizophrenia and not in their healthy young siblings. Clin Neurophysiol 2008, 119:2721-2726.
14. Egan M.F., Goldberg T.E., Kolachana B.S., Callicott J.H., Mazzanti C.M., Straub R.E., et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 2001, 98:6917-6922.
15. Euser A.S., Arends L.R., Evans B.E., Greaves-Lord K., Huizink A.C., Franken I.H. The P300 event-related brain potential as a neurobiological endophenotype for substance use disorders: a meta-analytic investigation. Neurosci Biobehav Rev 2012, 36:572-603.
16. Faul F., Erdfelder E., Lang A.G., Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007, 39:175-191.
17. Gallinat J., Bajbouj M., Sander T., Schlattmann P., Xu K., Ferro E.F., et al. Association of the G1947A COMT (Val(108/158)Met) gene polymorphism with prefrontal P300 during information processing. Biol Psychiatry 2003, 54:40-48.
18. Gogos J.A., Morgan M., Luine V., Santha M., Ogawa S., Pfaff D., et al. Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci USA 1998, 95:9991-9996.
19. Goldberg T.E., Egan M.F., Gscheidle T., Coppola R., Weickert T., Kolachana B.S., et al. Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia. Arch Gen Psychiatry 2003, 60:889-896.
20. Golimbet V., Gritsenko I., Alfimova M., Lebedeva I., Lezheiko T., Abramova L., et al. Association study of COMT gene Val158Met polymorphism with auditory P300 and performance on neurocognitive tests in patients with schizophrenia and their relatives. World J Biol Psychiatry 2006, 7:238-245.
21. Gordon E., Cooper N., Rennie C., Hermens D., Williams L.M. Integrative neuroscience. the role of a standardized database. Clin EEG Neurosci 2005, 36:64-75.
22. Gratton G., Coles M.G., Donchin E. A new method for off-line removal of ocular artifact. Electroencephalogr Clin Neurophysiol 1983, 55:468-484.
23. Guney F., Genc B.O., Kutlu R., Ilhan B.C. Auditory P300 event-related potential in tobacco smokers. J Clin Neurosci 2009, 16:1311-1315.
24. Hesselbrock V., Begleiter H., Porjesz B., O'Connor S., Bauer L. P300 event-related potential amplitude as an endophenotype of alcoholism-evidence from the collaborative study on the genetics of alcoholism. J Biomed Sci 2001, 8:77-82.
25. Hickie I.B., Davenport T.A., Naismith S.L., Scott E.M. On behalf of the SPHERE national secretariat. SPHERE a national depression project. Med J Aust 2001, 175:S2-S55.
26. Hill S.Y., Locke J., Zezza N., Kaplan B., Neiswanger K., Steinhauer S.R., et al. Genetic association between reduced P300 amplitude and the DRD2 dopamine receptor A1 allele in children at high risk for alcoholism. Biol Psychiatry 1998, 43:40-51.
27. Jeon Y.W., Polich J. Meta-analysis of P300 and schizophrenia: patients, paradigms, and practical implications. Psychophysiology 2003, 40:684-701.
28. Ji N., Shuai L., Chen Y., Liu L., Li H.M., Li Z.H., et al. Dopamine beta-hydroxylase gene associates with stroop color-word task performance in Han Chinese children with attention deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 2011, 156B:730-736.
29. Johnson R. On the neural generators of the P300 component of the event-related potential. Psychophysiology 1993, 30:90-97.
30. Joober R., Gauthier J., Lal S., Labelle A., Bloom D., Lalonde P., et al. Catechol-O-methyl-transferase Val108/158 met gene variants associated with performance on the Wisconsin card sorting test. Am J Med Genet B Neuropsychiatr Genet 2002, 114:853-854.
31. Kang C., Xu X., Liu H., Yang J. Association study of catechol-O-methyltransferase (COMT) gene Val158Met polymorphism with auditory P300 in Chinese Han patients with schizophrenia. Psychiatry Res 2010, 180:153-155.
32. Kenemans J.L., Kahkonen S. How human electrophysiology informs psychopharmacology: from bottom-up driven processing to top-down control. Neuropsychopharmacology 2011, 36:26-51.
33. Kieling C., Genro J.P., Hutz M.H., Rohde L.A. The -1021C/T DBH polymorphism is associated with neuropsychological performance among children and adolescents with ADHD. Am J Med Genet B Neuropsychiatr Genet 2008, 147B:485-490.
34. Kumakura Y., Vernaleken I., Buchholz H.G., Borghammer P., Danielsen E., Gründer G., et al. Age-dependent decline of steady state dopamine storage capacity of human brain: an FDOPA PET study. Neurobiol Aging 2010, 31:447-463.
35. Lachman H.M., Papolos D.F., Saito T., Yu Y.M., Szumlanski C.L., Weinshilboum R.M. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996, 6:243-250.
36. Lin C.H., Yu Y.W., Chen T.J., Tsa S.J., Hong C.J. Association analysis for dopamine D2 receptor Taq1 polymorphism with P300 event-related potential for normal young females. Psychiatr Genet 2001, 11:165-168.
37. Linden D.E. The P300: where in the brain is it produced and what does it tell us?. Neuroscientist 2005, 11:563-576.
38. Mier D., Kirsch P., Meyer-Lindenberg A. Neural substrates of pleiotropic action of genetic variation in COMT: a meta-analysis. Mol Psychiatry 2010, 15:918-927.
39. Mobascher A., Brinkmeyer J., Warbrick T., Wels C., Wagner M., Gründer G., et al. The P300 event-related potential and smoking - a population-based case-control study. Int J Psychophysiol 2010, 77:166-175.
40. Mulert C., Juckel G., Giegling I., Pogarell O., Leicht G., Karch S., et al. A Ser9Gly polymorphism in the dopamine D3 receptor gene (DRD3) and event-related P300 potentials. Neuropsychopharmacology 2006, 31:1335-1344.
41. Munafo M.R., Brown S.M., Hariri A.R. Serotonin transporter (5-HTTLPR) genotype and amygdala activation: a meta-analysis. Biol Psychiatry 2008, 63:852-857.
42. Murphy P.R., Robertson I.H., Balsters J.H., O'Connell R.G. Pupillometry and P3 index the locus coeruleus-noradrenergic arousal function in humans. Psychophysiology 2011, 48:1532-1543.
43. Nieuwenhuis S., Aston-Jones G., Cohen J.D. Decision making, the P3, and the locus coeruleus-norepinephrine system. Psychol Bull 2005, 131:510-532.
44. Noble E.P., Berman S.M., Ozkaragoz T.Z., Ritchie T. Prolonged P300 latency in children with the D2 dopamine receptor A1 allele. Am J Hum Genet 1994, 54:658-668.
45. Paul R.H., Gunstad J., Cooper N., Williams L.M., Clark C.R., Cohen R.A., et al. Cross-cultural assessment of neuropsychological performance and electrical brain function measures: additional validation of an international brain database. Int J Neurosci 2007, 117:549-568.
46. Pogarell O., Padberg F., Karch S., Segmiller F., Juckel G., Mulert C., et al. Dopaminergic mechanisms of target detection - P300 event related potential and striatal dopamine. Psychiatry Res 2011, 194:212-218.
47. Polich J. Clinical application of the P300 event-related brain potential. Phys Med Rehabil Clin N Am 2004, 15:133-161.
48. Polich J. Updating P300: an integrative theory of P3a and P3b. Clin Neurophysiol 2007, 118:2128-2148.
49. Polich J., Criado J.R. Neuropsychology and neuropharmacology of P3a and P3b. Int J Psychophysiol 2006, 60:172-185.
50. Polich J., Heine M.R. P300 topography and modality effects from a single-stimulus paradigm. Psychophysiology 1996, 33:747-752.
51. Savitz J., Solms M., Ramesar R. The molecular genetics of cognition: dopamine, COMT and BDNF. Genes Brain Behav 2006, 5:311-328.
52. Solowij N., Michie P.T., Fox A.M. Differential impairments of selective attention due to frequency and duration of cannabis use. Biol Psychiatry 1995, 37:731-739.
53. Stanzione P., Fattapposta F., Giunti P., D'Alessio C., Tagliati M., Affricano C., et al. P300 variations in parkinsonian patients before and during dopaminergic monotherapy: a suggested dopamine component in P300. Electroencephalogr Clin Neurophysiol 1991, 80:446-453.
54. Stein M.B., Fallin M.D., Schork N.J., Gelernter J. COMT polymorphisms and anxiety-related personality traits. Neuropsychopharmacology 2005, 30:2092-2102.
55. Sumich A.L., Kumari V., Heasman B.C., Gordon E., Brammer M. Abnormal asymmetry of N200 and P300 event-related potentials in subclinical depression. J Affect Disord 2006, 92:171-183.
56. Tunbridge E.M., Harrison P.J., Weinberger D.R. Catechol-O-methyltransferase, cognition, and psychosis: Val158Met and beyond. Biol Psychiatry 2006, 60:141-151.
57. Tsai S.J., Yu Y.W., Chen T.J., Chen J.Y., Liou Y.J., Chen M.C., et al. Association study of a functional catechol-O-methyltransferase-gene polymorphism and cognitive function in healthy females. Neurosci Lett 2003, 338:123-126.
58. van Beijsterveldt C.E., van Baal G.C. Twin and family studies of the human electroencephalogram: a review and a meta-analysis. Biol Psychol 2002, 61:111-138.
59. Williams L.M., Simms E., Clark C.R., Paul R.H., Rowe D., Gordon E. The test-retest reliability of a standardized neurocognitive and neurophysiological test battery: "neuromarker" Int J Neurosci 2005, 115:1605-1630.
60. Wild-Wall N., Falkenstein M., Gajewski P.D. Age-related differences in working memory performance in a 2-back task. Front Psychol 2011, 186:1-12.
61. Wronka E., Kaiser J., Coenen A.M. Neural generators of the auditory evoked potential components P3a and P3b. Acta Neurobiol Exp (Wars) 2012, 72:51-64.
62. Yue C., Wu T., Deng W., Wang G., Sun X. Comparison of visual evoked-related potentials in healthy young adults of different catechol-O-methyltransferase genotypes in a continuous 3-back task. Neuroreport 2009, 20:521-524.
63. Zabetian C.P., Anderson G.M., Buxbaum S.G., Elston R.C., Ichinose H., Nagatsu T., et al. A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus. Am J Hum Genet 2001, 68:515-522.